title: NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.
authors.affiliation: Northwestern University Feinberg School of Medicine, 676 North Saint Clair Street, Arkes Pavillion, 14-005, Chicago, IL 60527, USA.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Rinella
authors.affiliation: VCU School of Medicine, Virginia Commonwealth University, Box 980341, Richmond, VA 23298-0341, USA.
authors.forename: Arun J
authors.initials: AJ
authors.lastname: Sanyal
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D002635:Chenodeoxycholic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology; D008565:Membrane Proteins / Q000235:genetics; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*
chemical_list: D000924:Anticholesteremic Agents; D008565:Membrane Proteins; C419195:TM6SF2 protein, human; C464660:obeticholic acid; D002635:Chenodeoxycholic Acid